Oppenheimer launched its coverage of Alumis (NASDAQ:ALMS) with an Outperform recommendation and a 12–18-month price target of ...
In the wake of Oppenheimer, Christopher Nolan could do basically anything. His choice: go full Homer (no, not ‘The Simpsons ...